<div id="readability-page-1"><p>Core Scientific, Inc. (NASDAQ:CORZ - Get Free Report) Director Jarrod M. Patten acquired 1,500 shares of the stock in a transaction that occurred on Friday, August 30th. The stock was purchased at an average price of $9.95 per share, with a total value of $14,925.00. Following the transaction, the director now owns 280,739 shares in the company, valued at $2,793,353.05. The purchase was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this link.</p><div><p><span></span><span>Get <strong>Core Scientific</strong> alerts:</span></p></div><h2>Core Scientific Stock Performance</h2><p>CORZ traded down $0.92 during trading hours on Tuesday, hitting $9.40. 9,953,871 shares of the company's stock were exchanged, compared to its average volume of 8,215,329. Core Scientific, Inc. has a 1-year low of $2.61 and a 1-year high of $12.25. The stock's 50-day moving average is $9.98 and its two-hundred day moving average is $6.38. </p><p>Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its earnings results on Wednesday, August 7th. The company reported ($4.51) earnings per share for the quarter, missing analysts' consensus estimates of ($0.04) by ($4.47). The company had revenue of $141.10 million for the quarter, compared to analyst estimates of $128.58 million. The business's quarterly revenue was up 11.2% compared to the same quarter last year. Research analysts forecast that Core Scientific, Inc. will post 0.01 EPS for the current fiscal year. </p><h2>Wall Street Analysts Forecast Growth</h2><p>A number of research firms have issued reports on CORZ. B. Riley raised Core Scientific from a &#34;neutral&#34; rating to a &#34;buy&#34; rating and boosted their target price for the company from $0.50 to $13.00 in a research note on Wednesday, July 17th. HC Wainwright boosted their price objective on Core Scientific from $11.00 to $15.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, July 10th. LADENBURG THALM/SH SH restated a &#34;buy&#34; rating and set a $14.50 target price on shares of Core Scientific in a report on Tuesday, July 2nd. BTIG Research boosted their price objective on shares of Core Scientific from $10.00 to $15.00 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, June 26th. Finally, Sanford C. Bernstein began coverage on Core Scientific in a report on Wednesday, July 10th. They set an &#34;outperform&#34; rating and a $17.00 target price for the company. Seven analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of &#34;Buy&#34; and an average price target of $14.71.</p><p><b>Read Our Latest Stock Report on CORZ</b></p><h2>Institutional Investors Weigh In On Core Scientific</h2><p>A number of institutional investors and hedge funds have recently modified their holdings of CORZ. Banque Cantonale Vaudoise bought a new position in Core Scientific during the second quarter worth about $28,000. Sunbelt Securities Inc. acquired a new stake in Core Scientific during the second quarter worth approximately $33,000. Rise Advisors LLC bought a new position in Core Scientific during the 2nd quarter worth $65,000. Aspect Partners LLC acquired a new position in Core Scientific in the first quarter valued at about $29,000. Finally, Hexagon Capital Partners LLC bought a new position in Core Scientific in the first quarter valued at about $34,000. </p><h2>Core Scientific Company Profile</h2> (Get Free Report)<p>Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.</p><h2>Further Reading</h2><ul><li>Five stocks we like better than Core Scientific</li><li>What is a support level?</li><li>3 Small Cap Stocks That Insiders Are Buying</li><li>5 discounted opportunities for dividend growth investors</li><li>Analysts Forecast Big Upside for Western Digital—Don’t Miss Out</li><li>3 Grocery Stocks That Are Proving They Are Still Essential </li><li>3 Must-Own Stocks for Bullish Investors in Today's Market</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q09SWg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q09SWg"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><p>→ FREE Daily Profits Live Open House <span><span>(From Monument Traders Alliance)</span> <span>(Ad)</span></span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NDM5?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NDM5"/></p><h2>Should you invest $1,000 in Core Scientific right now?</h2><p>Before you consider Core Scientific, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.</p><p>While Core Scientific currently has a &#34;Buy&#34; rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p> </div>

CORZ

<p>Core Scientific, Inc. (NASDAQ:CORZ) Director Jarrod M. Patten acquired 1,500 shares on August 30th at an average price of $0.95 per share, totaling $1,425.00. Following this transaction, he owns 280,739 shares valued at approximately $793,353.05. The acquisition was noted in a filing with the SEC. Core Scientific's stock price has seen fluctuations, with a 1-year low of $0.61 and a high of $1.25. Analysts predict a current EPS of $0.01 and have raised price targets for the stock, reflecting a generally favorable outlook.</p>

Jarrod M. Patten Acquires 1,500 Shares of Core Scientific, Inc. (NASDAQ:CORZ) Stock